Skip to content

Advertisement

BMC Cancer

What do you think about BMC? Take part in

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Efficacy and safety of eribulin in patients with locally advanced or metastatic breast cancer not meeting trial eligibility criteria: a retrospective study

  • Sakura Iizumi1, 2,
  • Tatsunori Shimoi1, 3Email authorView ORCID ID profile,
  • Natsuko Tsushita1,
  • Seiko Bun4,
  • Akihiko Shimomura1,
  • Emi Noguchi1,
  • Makoto Kodaira5,
  • Mayu Yunokawa1,
  • Kan Yonemori1,
  • Chikako Shimizu1,
  • Yasuhiro Fujiwara1 and
  • Kenji Tamura1
BMC Cancer201717:819

https://doi.org/10.1186/s12885-017-3846-8

Received: 2 April 2017

Accepted: 24 November 2017

Published: 4 December 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
2 Apr 2017 Submitted Original manuscript
8 Aug 2017 Reviewed Reviewer Report - Katherine Tkaczuk
16 Aug 2017 Reviewed Reviewer Report - Ioannis Voutsadakis
5 Sep 2017 Reviewed Reviewer Report - Bora Lim
8 Oct 2017 Author responded Author comments - Sakura Iizumi
Resubmission - Version 2
8 Oct 2017 Submitted Manuscript version 2
27 Oct 2017 Reviewed Reviewer Report - Bora Lim
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
24 Nov 2017 Editorially accepted
4 Dec 2017 Article published 10.1186/s12885-017-3846-8

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Department of Breast and Medical Oncology, National Cancer Center Hospital
(2)
Keio University Graduate School of Medicine
(3)
Course of Advanced Clinical Research of Cancer, Juntendo University Graduate School of Medicine
(4)
Department of Pharmacy, National Cancer Center Hospital
(5)
Department of Medical Oncology, Kodaira Hospital

Advertisement